---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-026816"
form_type: "8-K"
ticker: "WINT"
cik: "0000946486"
company_name: "WINDTREE THERAPEUTICS INC /DE/"
filed_at: "2024-08-14T23:59:59+00:00"
generated_at: "2026-05-31T09:33:08.737760+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Windtree Therapeutics board reshuffled: two directors exit, two appointed, lead independent director named

## Summary
- Daniel Geffken and Leslie J. Williams resigned from the Board August 13, 2024; no disagreement with company.
- Board appointed Jed Latkin and Saundra Pelletier as directors; Latkin chairs Audit, Pelletier chairs Compensation.
- Mark Strobeck, Ph.D., appointed lead independent director effective August 13, 2024.

## SEC filing metadata
- accession: 0001437749-24-026816
- form_type: 8-K
- ticker: WINT
- cik: 0000946486
- company_name: WINDTREE THERAPEUTICS INC /DE/
- filed_at: 2024-08-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946486/000143774924026816/0001437749-24-026816-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946486/000143774924026816/wint20240812_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-026816
- JSON: https://secwatch.observer/filing/0001437749-24-026816.json
- Plain text: https://secwatch.observer/filing/0001437749-24-026816.txt

## Key facts
- Executive change
  Jed Latkin was appointed as Director at WINDTREE THERAPEUTICS INC /DE/.
  - Action: appointed
  - Role: Director
  source text: On August 13, 2024, the Board appointed Jed Latkin and Saundra Pelletier to fill the vacancies created by the resignation of Mr. Geffken and Ms. Williams, effective August 13, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/946486/000143774924026816/0001437749-24-026816-index.htm
- Executive change
  Daniel Geffken resigned as Director at WINDTREE THERAPEUTICS INC /DE/.
  - Action: resigned
  - Role: Director
  source text: On August 13, 2024, Daniel Geffken and Leslie J. Williams each notified Windtree Therapeutics, Inc. (the “Company”) of his or her resignation from the Board of Directors of the Company (the “Board”), including all committees of the Board on which he or she serves, effective August 13, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/946486/000143774924026816/0001437749-24-026816-index.htm
- Executive change
  Leslie J. Williams resigned as Director at WINDTREE THERAPEUTICS INC /DE/.
  - Action: resigned
  - Role: Director
  source text: On August 13, 2024, Daniel Geffken and Leslie J. Williams each notified Windtree Therapeutics, Inc. (the “Company”) of his or her resignation from the Board of Directors of the Company (the “Board”), including all committees of the Board on which he or she serves, effective August 13, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/946486/000143774924026816/0001437749-24-026816-index.htm
- Executive change
  Saundra Pelletier was appointed as Director at WINDTREE THERAPEUTICS INC /DE/.
  - Action: appointed
  - Role: Director
  source text: On August 13, 2024, the Board appointed Jed Latkin and Saundra Pelletier to fill the vacancies created by the resignation of Mr. Geffken and Ms. Williams, effective August 13, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/946486/000143774924026816/0001437749-24-026816-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.